Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
58.45
-1.50 (-2.50%)
At close: Apr 28, 2026, 4:00 PM EDT
58.48
+0.03 (0.05%)
After-hours: Apr 28, 2026, 7:59 PM EDT
Boston Scientific Stock Forecast
Stock Price Forecast
The 22 analysts with 12-month price forecasts for Boston Scientific stock have an average target of 93.18, with a low estimate of 71 and a high estimate of 128. The average target predicts an increase of 59.42% from the current stock price of 58.45.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Boston Scientific stock from 22 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 9 | 9 | 10 |
| Buy | 10 | 9 | 10 | 11 | 12 | 12 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 19 | 17 | 18 | 20 | 21 | 22 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $109 → $71 | Strong Buy | Maintains | $109 → $71 | +21.47% | Apr 23, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $105 → $100 | Buy | Maintains | $105 → $100 | +71.09% | Apr 23, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $90 → $85 | Strong Buy | Maintains | $90 → $85 | +45.42% | Apr 23, 2026 |
| Barclays | Barclays | Buy Maintains $100 → $96 | Buy | Maintains | $100 → $96 | +64.24% | Apr 23, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $80 → $78 | Buy | Maintains | $80 → $78 | +33.45% | Apr 23, 2026 |
Financial Forecast
Revenue This Year
22.45B
from 20.07B
Increased by 11.85%
Revenue Next Year
24.73B
from 22.45B
Increased by 10.16%
EPS This Year
3.49
from 1.94
Increased by 79.75%
EPS Next Year
3.95
from 3.49
Increased by 13.20%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 23.9B | 26.4B | |||||
| Avg | 22.5B | 24.7B | |||||
| Low | 21.5B | 23.5B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 18.8% | 17.6% | |||||
| Avg | 11.8% | 10.2% | |||||
| Low | 7.2% | 4.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 3.66 | 4.25 | |||||
| Avg | 3.49 | 3.95 | |||||
| Low | 3.35 | 3.70 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 88.9% | 22.0% | |||||
| Avg | 79.7% | 13.2% | |||||
| Low | 72.7% | 6.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.